Cisplatin and ultra-violet-C synergistically down-regulate receptor tyrosine kinases in human colorectal cancer cells
<p>Abstract</p> <p>Background</p> <p>Platinum-containing anti-cancer drugs such as cisplatin are widely used for patients with various types of cancers, however, resistance to cisplatin is observed in some cases. Whereas we have recently reported that high dose UV-C (20...
Main Authors: | Kawaguchi Junji, Adachi Seiji, Yasuda Ichiro, Yamauchi Takahiro, Nakashima Masanori, Ohno Tomohiko, Shimizu Masahito, Yoshioka Takashi, Itani Masahiko, Kozawa Osamu, Moriwaki Hisataka |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-07-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | http://www.molecular-cancer.com/content/11/1/45 |
Similar Items
-
Antitumor Efficacy and Mechanisms of Lapatinib in Combination with Cisplatin on Esophageal Squamous Cancer Cells
by: DOU Qiaohua, et al.
Published: (2019-09-01) -
Inhibition of Rho-associated coiled-coil containing protein kinase enhances the activation of epidermal growth factor receptor in pancreatic cancer cells
by: Okano Yukio, et al.
Published: (2011-07-01) -
ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway
by: Linlin Zhu, et al.
Published: (2018-06-01) -
Cisplatin Induced Nephrotoxicity
by: Seyed Seifollah Beladi Mousavi, et al.
Published: (2014-02-01) -
Cisplatin induces differentiation in teratomas derived from pluripotent stem cells
by: Atsushi Kurata, et al.
Published: (2021-12-01)